Header
Header
Article

New patent for Novo Nordisk drug SAXENDA

Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There are seventeen…
The post New patent for Novo Nordisk drug SAXENDA appeared first on DrugPatentWatch – Make Better Decisions.

The post New patent for Novo Nordisk drug SAXENDA appeared first on Biotechblog.

Source link

Back to top button